{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T16:35:25Z","timestamp":1720629325929},"reference-count":37,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,2,1]]},"abstract":"<jats:p>Thyroid-associated ophthalmopathy (TAO) is a progressive eye disorder associated with thyroid autoimmunity, particularly Graves\u2019 hyperthyroidism, which is generally considered to have an autoimmune etiology. Eye muscle membrane proteins reportedly of 55 and 64 kDa are the best markers of the ophthalmopathy. The main focus of our recent studies has been to purify the pertinent proteins from porcine eye muscle membranes and characterize them. The 64-kDa protein is now shown from a partial sequence and by Western blotting using specific antibody probes to be the flavoprotein (Fp) subunit of succinate dehydrogenase and to have a correct molecular mass of 67 kDa. The protein was purified and cleaved with cyanogen bromide, and the N-terminal region of an immunoreactive partial peptide was determined. The 20-amino acid porcine sequence so obtained matched one within the Fp subunits of human and bovine succinate dehydrogenases in 20 and 18 of these positions, respectively. Succinate dehydrogenase is both a citric acid cycle enzyme and a component (complex II) of the mitochondrial respiratory chain. It is thus essential for aerobic energy production and is highly conserved. The mature human and bovine Fp subunits are 92% homologous and have a molecular mass of \u223c67 kDa, the same as our redetermined value for the 64-kDa marker protein. Sera from patients with TAO and from those with Graves\u2019 hyperthyroidism without evident ophthalmopathy highlighted the 64-kDa marker protein in crude porcine eye muscle membranes and the Fp subunit of highly purified bovine succinate dehydrogenase at the identical position on Western blots. Anti-beef Fp antibodies were detected in sera from 67% of patients with active TAO of more than 1-yr duration, in 30% with stable TAO of more than 3-yr duration, and in 30% of patients with Graves\u2019 hyperthyroidism without ophthalmopathy, but in only 7% of age- and sex-matched normal subjects. As succinate dehydrogenase is bound to the matrix (inside) surface of the mitochondrial inner membrane, it is unlikely to be accessible to circulating autoantibodies. We would postulate that eye muscle damage in ophthalmopathy is probably caused by cytotoxic antibodies or CD+ T lymphocytes targeting a cell membrane antigen, such as the thyroid and eye muscle shared protein G2s, and that presentation of succinate dehydrogenase is secondary. On the other hand, an autoantibody response to succinate dehydrogenase may be a good marker of immune-mediated damage to the eye muscle fiber and may support the idea that the extraocular muscles are targets of the autoimmune reactions of TAO.<\/jats:p>","DOI":"10.1210\/jcem.83.2.4553","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:02:56Z","timestamp":1389200576000},"page":"443-447","source":"Crossref","is-referenced-by-count":3,"title":["The 64-Kilodalton Eye Muscle Protein Is the Flavoprotein Subunit of Mitochondrial Succinate Dehydrogenase: The Corresponding Serum Antibodies Are Good Markers of an Immune-Mediated Damage to the Eye Muscle in Patients with Graves\u2019 Hyperthyroidism1"],"prefix":"10.1210","volume":"83","author":[{"given":"S.","family":"Kubota","sequence":"first","affiliation":[{"name":"Departments of Medicine and Ophthalmology, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212; the Department of Veterans Affairs Medical Center and Department of Biochemistry and Biophysics, University of California (B.A.C.A., B.C.), San Francisco, California 94121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Gunji","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Ophthalmology, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212; the Department of Veterans Affairs Medical Center and Department of Biochemistry and Biophysics, University of California (B.A.C.A., B.C.), San Francisco, California 94121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. A. C.","family":"Ackrell","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Ophthalmology, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212; the Department of Veterans Affairs Medical Center and Department of Biochemistry and Biophysics, University of California (B.A.C.A., B.C.), San Francisco, California 94121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Cochran","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Ophthalmology, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212; the Department of Veterans Affairs Medical Center and Department of Biochemistry and Biophysics, University of California (B.A.C.A., B.C.), San Francisco, California 94121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Stolarski","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Ophthalmology, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212; the Department of Veterans Affairs Medical Center and Department of Biochemistry and Biophysics, University of California (B.A.C.A., B.C.), San Francisco, California 94121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wengrowicz","sequence":"additional","affiliation":[{"name":"the Endocrine Research Laboratory, Hospital de Sant Pau, Autonomous University of Barcelona (S.W.), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Kennerdell","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Ophthalmology, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212; the Department of Veterans Affairs Medical Center and Department of Biochemistry and Biophysics, University of California (B.A.C.A., B.C.), San Francisco, California 94121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hiromatsu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology (Y.H.), Kurume University School of Medicine, Kurume, Japan 830"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wall","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Ophthalmology, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212; the Department of Veterans Affairs Medical Center and Department of Biochemistry and Biophysics, University of California (B.A.C.A., B.C.), San Francisco, California 94121"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071618325757400_R1","first-page":"747","article-title":"Graves\u2019 ophthalmopathy: current concepts regarding pathogenesis and management.","volume":"14","author":"Burch","year":"1993","journal-title":"Endocr Rev"},{"key":"2020071618325757400_R2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0140-6736(91)90013-F","article-title":"Thyroid-associated eye disease: pathophysiology.","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"2020071618325757400_R3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/clin.1993.1087","article-title":"Pathogenesis of thyroid associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves\u2019 hyperthyroidism and Hashimoto\u2019s thyroiditis.","volume":"68","author":"Wall","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"2020071618325757400_R4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000236845","article-title":"The fibroblast is the target cell in the connective tissue manifestations of Graves\u2019 disease.","volume":"106","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"2020071618325757400_R5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/thy.1995.5.331","article-title":"Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves\u2019 ophthalmopathy.","volume":"5","year":"1995","journal-title":"Thyroid"},{"key":"2020071618325757400_R6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0140-6736(93)91475-2","article-title":"Expression of thyrotropin-receptor mRNA in healthy and Graves\u2019 disease retro-orbital tissue.","volume":"342","author":"Feliciello","year":"1993","journal-title":"Lancet"},{"key":"2020071618325757400_R7","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1074\/jbc.270.18.10833","article-title":"Cloning, and functional expression of a thyrotropin receptor cDNA from fat cells.","volume":"270","author":"Endo","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071618325757400_R8"},{"key":"2020071618325757400_R9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000236844","article-title":"The ocular muscle cell is a target of the immune system in endocrine ophthalmopathy-Pro.","volume":"106","author":"Kiljanski","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"2020071618325757400_R10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08916939309077351","article-title":"Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative Western blot.","volume":"14","author":"Hiromatsu","year":"1993","journal-title":"Autoimmunity"},{"key":"2020071618325757400_R11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0090-1229(92)90219-E","article-title":"Identification of autoantigen recognized by autoimmune ophthalmopathy sera with immunoblotting correlated with orbital computed tomography.","volume":"65","author":"Chang","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"2020071618325757400_R12"},{"key":"2020071618325757400_R13","first-page":"975","article-title":"Orbital pathology in Graves\u2019 disease.","volume":"47","year":"1972","journal-title":"Mayo Clinic Proc"},{"key":"2020071618325757400_R14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-5793(88)80402-2","article-title":"Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy.","volume":"232","author":"Salvi","year":"1988","journal-title":"FEBS Lett"},{"key":"2020071618325757400_R15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/thy.1991.1.207","article-title":"Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.","volume":"1","author":"Salvi","year":"1991","journal-title":"Thyroid"},{"key":"2020071618325757400_R16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/thy.1992.2.197","article-title":"Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity.","volume":"2","author":"Miller","year":"1992","journal-title":"Thyroid"},{"key":"2020071618325757400_R17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/thy.1996.6.353","article-title":"Serum eye muscle and TSH receptor antibodies predicted the development of ophthalmopathy in a euthyroid subject with a family history of autoimmunity.","volume":"6","author":"Wall","year":"1966","journal-title":"Thyroid"},{"key":"2020071618325757400_R18"},{"key":"2020071618325757400_R19"},{"key":"2020071618325757400_R20"},{"key":"2020071618325757400_R21","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1210\/jcem-63-4-990","article-title":"The lack of specificity of ophthalmic immunoglobulins in Graves\u2019 disease.","volume":"63","author":"Kadlubowski","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618325757400_R22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jcem-64-3-454","article-title":"Antibodies to porcine eye muscle in patients with Graves\u2019 ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme linked immunosorbent assay.","volume":"64","author":"Ahmann","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618325757400_R23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2265.1994.tb03015.x","article-title":"Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy.","volume":"40","author":"Tandon","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618325757400_R24"},{"key":"2020071618325757400_R25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/thy.1992.2.235","article-title":"Classification of eye changes of Graves\u2019 disease.","volume":"2","year":"1992","journal-title":"Thyroid"},{"key":"2020071618325757400_R26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during assembly of the head of bacteriophage T4.","volume":"227","year":"1970","journal-title":"Nature"},{"key":"2020071618325757400_R27","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1021\/bi00789a014","article-title":"Succinate dehydrogenase. I. Purification, molecular properties, and substructure.","volume":"10","author":"Davis","year":"1971","journal-title":"Biochemistry"},{"key":"2020071618325757400_R28","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1016\/S0021-9258(18)63662-2","article-title":"Reconstitution of succinate dehydrogenase-coenzyme Q reductase (complex II) and succinate oxidase activities by a highly purified, reactivated, succinate dehydrogenase.","volume":"244","author":"Baginsky","year":"1969","journal-title":"J Biol Chem"},{"key":"2020071618325757400_R29","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1021\/bi00575a001","article-title":"Arrangement of complex II (succinateubiquinone reductase) in the mitochondrial inner membrane.","volume":"18","author":"Merli","year":"1979","journal-title":"Biochemistry"},{"key":"2020071618325757400_R30"},{"key":"2020071618325757400_R31"},{"key":"2020071618325757400_R32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0005-2728(94)90203-8","article-title":"The cDNA sequence of the flavoprotein subunit of human heart succinate dehydrogenase.","volume":"1185","author":"Morris","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"2020071618325757400_R33","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0006-291X(90)91916-G","article-title":"Human complex II (succinate-ubiquinone oxidireductase): cDNA cloning of iron sulfur (Ip) subunit of liver mitochondria.","volume":"166","author":"Kita","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071618325757400_R34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0378-1119(95)00162-Y","article-title":"Structural organization of the gene encoding the human iron-sulfur subunit of succinate dehydrogenase.","volume":"159","author":"Au","year":"1995","journal-title":"Gene"},{"key":"2020071618325757400_R35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1997.tb52068.x","article-title":"Nuclear localization of autoantibodies. Novel insights into protein translocation and cellular function.","volume":"815","author":"Madaio","year":"1997","journal-title":"Ann NY Acad Sci"},{"key":"2020071618325757400_R36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/brain\/118.2.339","article-title":"Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients.","volume":"118","author":"Jackson","year":"1995","journal-title":"Brain"},{"key":"2020071618325757400_R37"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/83\/2\/443\/9229512\/jcem0443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/83\/2\/443\/9229512\/jcem0443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T23:48:40Z","timestamp":1647906520000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/83\/2\/443\/2865291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2,1]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.83.2.4553","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2,1]]}}}